Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors
- PMID: 12696053
- DOI: 10.1002/prot.10362
Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors
Abstract
G-protein coupled receptors (GPCRs) are the largest family of cell-surface receptors involved in signal transmission. Drugs associated with GPCRs represent more than one fourth of the 100 top-selling drugs and are the targets of more than half of the current therapeutic agents on the market. Our methodology based on the internal coordinate mechanics (ICM) program can accurately identify the ligand-binding pocket in the currently available crystal structures of seven transmembrane (7TM) proteins [bacteriorhodopsin (BR) and bovine rhodopsin (bRho)]. The binding geometry of the ligand can be accurately predicted by ICM flexible docking with and without the loop regions, a useful finding for GPCR docking because the transmembrane regions are easier to model. We also demonstrate that the native ligand can be identified by flexible docking and scoring in 1.5% and 0.2% (for bRho and BR, respectively) of the best scoring compounds from two different types of compound database. The same procedure can be applied to the database of available chemicals to identify specific GPCR binders. Finally, we demonstrate that even if the sidechain positions in the bRho binding pocket are entirely wrong, their correct conformation can be fully restored with high accuracy (0.28 A) through the ICM global optimization with and without the ligand present. These binding site adjustments are critical for flexible docking of new ligands to known structures or for docking to GPCR homology models. The ICM docking method has the potential to be used to "de-orphanize" orphan GPCRs (oGPCRs) and to identify antagonists-agonists for GPCRs if an accurate model (experimentally and computationally validated) of the structure has been constructed or when future crystal structures are determined.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.J Mol Biol. 2008 Oct 3;382(2):539-55. doi: 10.1016/j.jmb.2008.06.084. Epub 2008 Jul 7. J Mol Biol. 2008. PMID: 18638482
-
Protein flexibility in ligand docking and virtual screening to protein kinases.J Mol Biol. 2004 Mar 12;337(1):209-25. doi: 10.1016/j.jmb.2004.01.003. J Mol Biol. 2004. PMID: 15001363
-
Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.J Comput Chem. 2009 Jan 15;30(1):14-32. doi: 10.1002/jcc.21001. J Comput Chem. 2009. PMID: 18496794
-
A G protein-coupled receptor at work: the rhodopsin model.Trends Biochem Sci. 2009 Nov;34(11):540-52. doi: 10.1016/j.tibs.2009.07.005. Epub 2009 Oct 21. Trends Biochem Sci. 2009. PMID: 19836958 Review.
-
Modeling the 3D structure of GPCRs: advances and application to drug discovery.Curr Opin Drug Discov Devel. 2003 May;6(3):353-61. Curr Opin Drug Discov Devel. 2003. PMID: 12833668 Review.
Cited by
-
Effects of Post-translational Modifications on Membrane Localization and Signaling of Prostanoid GPCR-G Protein Complexes and the Role of Hypoxia.J Membr Biol. 2019 Oct;252(4-5):509-526. doi: 10.1007/s00232-019-00091-4. Epub 2019 Sep 4. J Membr Biol. 2019. PMID: 31485700 Review.
-
Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism.Oncogene. 2015 Mar 5;34(10):1220-30. doi: 10.1038/onc.2014.67. Epub 2014 Mar 24. Oncogene. 2015. PMID: 24662830 Free PMC article.
-
G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules.Int J Mol Sci. 2019 Nov 7;20(22):5568. doi: 10.3390/ijms20225568. Int J Mol Sci. 2019. PMID: 31703453 Free PMC article. Review.
-
2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling.ChemMedChem. 2009 Oct;4(10):1615-29. doi: 10.1002/cmdc.200900226. ChemMedChem. 2009. PMID: 19637157 Free PMC article.
-
Virtual ligand screening against comparative protein structure models.Methods Mol Biol. 2012;819:105-26. doi: 10.1007/978-1-61779-465-0_8. Methods Mol Biol. 2012. PMID: 22183533 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources